Article info

Protocol
Prevention of vasoplegia with CytoSorb in heart failure patients undergoing cardiac surgery (CytoSorb-HF trial): protocol for a randomised controlled trial

Authors

  1. Correspondence to Dr Meindert Palmen; M.Palmen{at}lumc.nl
View Full Text

Citation

Papazisi O, Bruggemans EF, Berendsen RR, et al
Prevention of vasoplegia with CytoSorb in heart failure patients undergoing cardiac surgery (CytoSorb-HF trial): protocol for a randomised controlled trial

Publication history

  • Received February 21, 2022
  • Accepted August 12, 2022
  • First published September 19, 2022.
Online issue publication 
March 28, 2024
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.